Tag: Russian Pharma

Vision of Russia’s Generic Market Development

The human body is subject to many diseases, so without drugs it simply can not cope. The health of people, the improvement of the quality of life and its duration are the main goals of pharmaceutical ...

Prospects of Cooperation between Russian and Korean Regulators

On June 26-28, «Bio Innovation, New-Found Future» Global BIO Conference (GBC) 2019 took place in Seoul (Republic of Korea), in the framework of which the working sessions were held with senior represe...

Relation to Regulatory Specifics of the Pharma Market in Russia and EEU

The new video of TRUBOR ONLINE is prepared in Spanish (with English subtitles) and provides a helicopter view in relation to regulatory specifics of the market access in the pharmaceutical sector in R...

New Phase of Mandatory Drug Labeling in Russia

In Russia, a new phase of mandatory labeling of drugs begins. From July 1 to July 8, manufacturers, distributors, pharmacies are required to register in the Drug Movement Monitoring (DMM) system to wo...

Pharmapark and Prestige Biopharma Announce Licensing Agreement for Bioanalogue of Trastuzumab

biosimilars
Russian pharmaceutical company Pharmapark, a company owned by Pharmstandard, and Singapore-based group Prestige Biopharma, entered into a licensing agreement for the delivery of a bioanalogue of trast...

Russian Pharma Companies Suspected of Obstructing Inspections

FAS Russia
FAS is carrying out inspections of some pharmaceutical distributors and government customers on suspicion of organizing the largest pharma cartel FAS, with support from the law enforcement bodies, ...

Russian Digital Agency Fined for Violating Legislation Med Ad

Russia’s Federal Antimonopoly Service has fined Traffic Isobar digital agency 200,000 rubles (over $3,000) for inaccurate medicine advertising, the watchdog’s statement reads. In April 2019, the FA...

What to Expect from Russian GMP Inspection

Although the idea and content of GMP guidance in different countries or regions is quite comparable, there are no common global GMP regulations - and inspectors from various national competent authori...

Total Volume of Drug Production in Russia since January Amounted to €2bn

Today, the Russian pharmaceutical market is one of the most dynamic and fast-growing in the world. In this area, there is an active import substitution. A significant part of the drugs produced in Rus...

Nuclear Medicine Center, Biotech Laboratory to be Set Up in Skolkovo Medical Cluster

skolkovo
Skolkovo Foundation concluded six agreements to facilitate medical, educational and research projects in healthcare at the St. Petersburg international economic forum. A versatile full-cycle biotec...

Director of SID & GP Opened New Manufacturing Site

Within the Saint Petersburg International Economic Forum, a formal opening of a new manufacturing site «Severnaya Zvezda» took place. Expansion of production capacities is a step towards strengthenin...

Abbott to Start Making Syringes, Nasal Drops in Vladimir Region

The U.S. pharmaceutical company Abbott which owns a 100% stake in Veropharm, and the Vladimir regional administration have signed a memorandum of cooperation. The agreement was signed on the sideli...

Drug Production to be Launched in Moscow Special Economic Zone

drug manufacturing
An agreement clearing the pharmaceutical company R-Opra to manufacture drugs in the Technopolis Moscow special economic zone was concluded at the St. Petersburg international economic forum. Under ...

Kurganpribor, LRS Engineering Team Up to Manufacture Coronary Stents

medical-devices
Kurganpribor, LRS Engineering Team up to manufacture coronary stents. NPO Kurganpribor, a joint-stock company based in Kurgan, and Germany’s LRS Engineering have signed a cooperation agreement to make...

Export Potential of Russian Pharmaceuticals

At this year’s Saint Petersburg International Economic Forum, special consideration is given to the topics of pharmaceuticals, medicine, and healthcare. As one of the key objectives set by Pharma 2030...

JV of Russian and Chinese Companies May Float Shares

A joint venture of Russian pharmaceutical company Biocad and China’s Shanghai Pharmaceuticals Holding may float shares at the Hong Kong Stock Exchange, Biocad CEO Dmitry Morozov told PRIME, a day afte...